PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DIA Annual EuroMeeting - Diapharm Pushes for a Paradigm Shift in the Legislation for OTC Products - Dr Annemarie Jasper from the pharmaceutical service provider Diapharm maintains that European lawmakers are not differentiating between Rx and OTC and called for a legislatory paradigm shift during the DIA AnnualEuro Meeting
DIA Annual EuroMeeting - Diapharm Pushes for a Paradigm Shift in the Legislation for OTC Products

 

NewswireToday - /newswire/ - Muenster, North Rhine-Westfalia, Germany, 2010/03/10 - Dr Annemarie Jasper from the pharmaceutical service provider Diapharm maintains that European lawmakers are not differentiating between Rx and OTC and called for a legislatory paradigm shift during the DIA AnnualEuro Meeting.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Due to the undifferentiated regulations in the European market for over-the-counter (OTC) medicinal products, a paradigm shift in the legislation is overdue. This point was emphasised by Dr Annemarie Jasper, manager of business development services for the pharmaceutical service provider Diapharm during the DIA 22nd Annual EuroMeeting in Monaco. At the largest European symposium for the pharmaceutical sector, which was attended by more than 3,000 experts from private companies, public authorities and universities, Jasper criticised the constant growth in legal regulations that are valid not only for medicinal products requiring prescriptions, but also for non-prescription OTC products.

National procedures have been preferred until now in the OTC market
The expert demanded a general easing of restrictions for the authorisation of OTCs and so-called ’well-known substances‘. In her lecture at the session entitled “New Chances for well-known substances: CP or MRP/DCP” (Session 0608), she suggested an expansion of the THMP-directive (2004/24/EC) into a TMPD. She also stressed the differences in the management of regulations by the different EU countries. Because of these differences, manufacturers of OTC medicinal products very often use national authorisation procedures. “We are demanding that our political leaders create adequate incentives so that international procedures such as MRP and DCP can become more applicable for the OTC industry.”

Lawmakers are not differentiating between Rx and OTC
As a whole, the regulatory requirements for OTCs are overextended: “As long as lawmakers fail to distinguish between OTC and Rx medicinal products, the relatively harmless OTCs that do not require prescriptions are being burdened with disproportionate requirements and are all too often trivialized with product claims that are far too weak”, Jasper said. As a first sign of this change in perspective, she pointed to the 2004/24/EU directive for traditional herbal medicinal products. This allows phyto-pharmaceuticals to be registered under certain circumstances by using a simplified procedure. She asked that this procedure be established not only for herbals, but for well-known OTC substances in general. “Working towards this goal should be an urgent task for the pharmaceutical industry in Europe,” explains Dr Annemarie Jasper.

Diapharm (diapharm.com), which has offices in Germany, Great Britain and Romania, was also present at the symposium in Monaco with its own booth (no. 181-182). Diapharm is a full-service provider for the healthcare industry. Founded in 1988, Diapharm supports pharmaceutical companies in all questions concerning regulatory affairs, medical & clinical development, quality and business development.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Werbeagentur & PR-Agentur co-operate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DIA Annual EuroMeeting - Diapharm Pushes for a Paradigm Shift in the Legislation for OTC Products

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Christian Rieke - Co-Operate.net 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Werbeagentur & PR-Agentur co-operate securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Werbeagentur & PR-Agentur co-operate / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)